Research Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial Deanfield J., Lincoff A.M., Kahn S.E., et al
Close glucose monitoring during dialysis transitions
CL Answer Is MitoQ a better form of CoQ10
Understanding the Study Timeline: Phase 2a vs Phase 3 Phase 2a MASLD Substudy (2023) - SOURCE OF 86% RESOLUTION DATA Status: COMPLETED and published Study Design: Part of larger Phase 2 obesity trial (NEJM 2023) Focused substudy on patients with MASLD Liver fat measured by MRI-PDFF (gold standard) Duration: 48 weeks Published results available This is where the 82.4% liver fat reduction and 86% resolution rate data comes from
Working with a provider who understands GLP-1 medications can help you develop a personalized plan, whether that involves continuing treatment at a reduced dose, switching medications, or managing the transition off medication entirely
Interleukin-17/interleukin-17 receptor axis elicits intestinal neutrophil migration, restrains gut dysbiosis and lipopolysaccharide translocation in high-fat diet-induced metabolic syndrome model